Antiadhesin Peptide-Based Vaccines for Pseudomonas aeruginosa

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/B978-0-12-385095-9.00077-4
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Recent developments for Pseudomonas vaccines

  2011cited by this paper
• New treatment options for infections caused by multiresistant strains of Pseudomonas aeruginosa and other nonfermenting gram-negative bacilli.

  2011cited by this paper
• Pseudomonas aeruginosa: all roads lead to resistance.

  2011cited by this paper
• Emerging Resistant Gram-Negative Aerobic Bacilli in Hospital-Acquired Infections

  2010cited by this paper
• Research Article: Synthetic Peptide Vaccine Development: Designing Dual Epitopes into a Single Pilin Peptide Immunogen Generates Antibody Cross‐reactivity between Two Strains of Pseudomonas aeruginosa

  2010cited by this paper
• Pseudomonas aeruginosa - a phenomenon of bacterial resistance.

  2009cited by this paper
• The use of synthetic peptides in the design of a consensus sequence vaccine for Pseudomonas aeruginosa.

  2009cited by this paper
• NMR solution structure of the receptor binding domain of Pseudomonas aeruginosa pilin strain P1. Identification of a β‐turn

  2009cited by this paper
• Advantages of a Synthetic Peptide Immunogen Over a Protein Immunogen in the Development of an Anti‐Pilus Vaccine for Pseudomonas aeruginosa

  2009cited by this paper
• Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.

  2009cited by this paper
• Vaccines and immunotherapy against Pseudomonas aeruginosa.

  2008cited by this paper
• More than one reason to rethink the use of peptides in vaccine design

  2007cited by this paper
• Animal protection and structural studies of a consensus sequence vaccine targeting the receptor binding domain of the type IV pilus of Pseudomonas aeruginosa.

  2007cited by this paper
• The Pseudomonas aeruginosa type IV pilin receptor binding domain functions as an adhesin for both biotic and abiotic surfaces

  2006cited by this paper
• Pseudomonas aeruginosa: the potential to immunise against infection

  2005cited by this paper
• Crystallographic analysis of the Pseudomonas aeruginosa strain K122-4 monomeric pilin reveals a conserved receptor-binding architecture.

  2004cited by this paper
• Type IV pilus structure and bacterial pathogenicity

  2004cited by this paper
• Synthetic peptide vaccine development: measurement of polyclonal antibody affinity and cross‐reactivity using a new peptide capture and release system for surface plasmon resonance spectroscopy

  2004cited by this paper
• Synthetic peptide vaccine and antibody therapeutic development: Prevention and treatment of Pseudomonas aeruginosa

  2003cited by this paper
• Dissecting the role of peptides in the immune response: theory, practice and the application to vaccine design

  2003cited by this paper
• Type IV pilin structure and assembly: X-ray and EM analyses of Vibrio cholerae toxin-coregulated pilus and Pseudomonas aeruginosa PAK pilin.

  2003cited by this paper
• Type IV pili and twitching motility.

  2002cited by this paper
• Crystal structure of Pseudomonas aeruginosa PAK pilin suggests a main-chain-dominated mode of receptor binding.

  2000cited by this paper
• Comparison of NMR solution structures of the receptor binding domains of Pseudomonas aeruginosa pili strains PAO, KB7, and PAK: implications for receptor binding and synthetic vaccine design.

  1996cited by this paper
• Anti-adhesin antibodies that recognize a receptor-binding motif (adhesintope) inhibit pilus/fimbrial-mediated adherence of Pseudomonas aeruginosa and Candida albicans to asialo-GM1 receptors and human buccal epithelial cell surface receptors.

  1996cited by this paper
• Manipulation of the helper T cell response to influence antigenic competition occurring with a multivalent vaccine

  1996cited by this paper
• Structure-function analysis of the adherence-binding domain on the pilin of Pseudomonas aeruginosa strains PAK and KB7.

  1995cited by this paper
• Immunological parameters associated with antigenic competition in a multivalent footrot vaccine.

  1995cited by this paper
• NMR solution structure and flexibility of a peptide antigen representing the receptor binding domain of Pseudomonas aeruginosa.

  1994cited by this paper
• The binding of Pseudomonas aeruginosa pili to glycosphingolipids is a tip‐associated event involving the C‐terminal region of the structural pilin subunit

  1994cited by this paper
• The pili of Pseudomonas aeruginosa strains PAK and PAO bind specifically to the carbohydrate sequence βGalNAc(1–4)βGal found in glycosphingolipids asialo‐GM1 and asialo‐GM2

  1994cited by this paper
• Antigenic competition in a multivalent foot rot vaccine.

  1994cited by this paper
• Alteration of the pilin adhesin of Pseudomonas aeruginosa PAO results in normal pilus biogenesis but a loss of adherence to human pneumocyte cells and decreased virulence in mice

  1994cited by this paper
• Fimbriae (pili): molecular basis of Pseudomonas aeruginosa adherence.

  1986cited by this paper
• Influence of genetic factors on natural resistance of mice to Pseudomonas aeruginosa.

  1979cited by this paper

• Peptide-based synthetic vaccines

  2015cites this paper